CDXC Stock News Chromadex Corp (CDXC) 1.3700 07/25/2014 09:4

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Chromadex Corp (CDXC) 1.3700 $CDXC

ChromaDex Initiates First Human Clinical Study to Confirm ChromaDex's NIAGEN(TM) Nicotinamide Riboside Will Increase NAD+
PR Newswire - Wed Jul 16, 7:25AM CDT
ChromaDex Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today the initiation of the first human clinical study for its patented ingredient NIAGEN(TM), the first and only commercially available form of nicotinamide riboside (NR). The study will engage the laboratory of Dr. Charles Brenner, Roy J. Carver Chair of Biochemistry and Professor of Internal Medicine at University of Iowa. Brenner, is credited with discovery of NR as a vitamin in organisms from yeast to people as published in Cell in 2004.

Nobel Laureate Roger Kornberg to Chair New ChromaDex Scientific Advisory Board
PR Newswire - Tue Jul 08, 7:20AM CDT
ChromaDex Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today it has appointed Nobel Laureate Roger Kornberg to Chair the Company's newly formed Scientific Advisory Board ("SAB".

ChromaDex to evaluate natural product libraries in research partnership with St Jude Children's Research Hospital
M2 - Fri Jun 20, 7:32AM CDT
Natural products company ChromaDex (Other OTC:CDXC) revealed on Thursday that it intends to evaluate its natural product libraries in a research based partnership with St Jude Children's Research Hospital.

ChromaDex Signs Collaboration Research Agreement with St. Jude Children's Research Hospital
PR Newswire - Thu Jun 19, 7:25AM CDT
ChromaDex Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today it has entered into a joint collaboration agreement with St. Jude Children's Research Hospital to evaluate ChromaDex's natural product libraries.

ChromaDex Licenses Exclusive Patent Rights from Dartmouth College for Pharmaceutical Use of Nicotinamide Riboside (NR)
PR Newswire - Tue Jun 03, 5:30AM CDT
ChromaDex Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today it has licensed exclusive rights from Dartmouth College for several patents related to pharmaceutical use of nicotinamide riboside (NR). The new licensed patents include protection for human therapeutic uses of NR and build upon the patents licensed from Dartmouth in 2012 for other human uses and production methods of NR.

/C O R R E C T I O N -- ChromaDex Corporation/
PR Newswire - Fri May 30, 7:03PM CDT
In the news release, ChromaDex CEO to Present at the Jefferies 2014 Global Healthcare Conference, issued 30-May-2014 by ChromaDex Corporation over PR Newswire, we are advised by the company that the financial table at the end of the release should not be included. The complete, corrected release follows:

ChromaDex CEO to Present at the Jefferies 2014 Global Healthcare Conference
PR Newswire - Fri May 30, 7:25AM CDT
ChromaDex Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today that Frank L. Jaksch, Jr., founder and CEO of ChromaDex, will present at the Jefferies 2014 Global Healthcare Conference in New York on Tuesday, June 3, 2014, at 2:00 p.m. EDT.

ChromaDex and JQMS Announce Exclusive Sales and Marketing Agreement for GMP Compliance Services
PR Newswire - Wed May 28, 7:25AM CDT
ChromaDex Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, and Joy's Quality Management Systems, Inc. (JQMS), a leading consulting firm for regulatory compliance and training services, announced today that ChromaDex has been designated as the exclusive sales and marketing agent for JQMS' services.

ChromaDex Announces Second Human Clinical Trial
ACCESSWIRE - Wed May 21, 8:28AM CDT
ChromaDex Inc. (OTCQB: CDXC) saw its share volume soar on May 20th with 224,975 shares exchanging hands, significantly higher than its three month daily average volume of 143,835 shares.

ChromaDex® CEO to Present at 15th Annual B. Riley Conference on May 19th at 9:30 am PDT / 12:30 pm EDT
PR Newswire - Wed May 14, 7:25AM CDT
ChromaDex Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today that its CEO, Frank Jaksch, will present at the 15th Annual B. Riley & Co. Investor Conference to be held at May 19th - 21st at the Loews Santa Monica Beach Hotel in Santa Monica, CA.

Thorne Research Introduces a New Product, NiaCel(TM), Featuring NIAGEN(TM), To Support Healthy Aging
PR Newswire - Wed Apr 02, 7:30AM CDT
Thorne Research today announced the launch of NiaCel(TM), an innovative nutritional supplement that supports endurance, energy, and healthy aging. NiaCel(TM) is one of the first commercially available products to feature the ingredient NIAGEN(TM) from ChromaDex Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic, and pharmaceutical industries.

ChromaDex® Reports 2013 Full-Year Results
PR Newswire - Thu Mar 27, 5:45AM CDT
ChromaDex® Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today the financial results for the year ended December 28, 2013.

ChromaDex Signs Material Transfer Agreement With Leading Dutch University for NIAGEN(TM) Research
PR Newswire - Wed Mar 12, 7:25AM CDT
ChromaDex Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today it has entered into a material transfer agreement (MTA) with the Groningen Biomolecular Sciences & Biotechnology Institute (GBB), a leading research institute at the University of Groningen in the Netherlands. ChromaDex will provide GBB with quantities of its proprietary NIAGEN(TM) nicotinamide riboside (NR) ingredient.

ChromaDex to Present at the 26th Annual ROTH Conference on March 10th at 4:30 pm PDT
PR Newswire - Thu Mar 06, 7:20AM CST
ChromaDex Corp.® (OTCQB: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today that its CEO, Frank Jaksch, will present at the 26th Annual ROTH Conference, which will take place from March 9-12 at the Ritz-Carlton Laguna Niguel in Dana Point, Calif.

RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg
GlobeNewswire - Thu Feb 27, 8:59AM CST
RedChip Companies, Inc. ("RedChip", an international small-cap research, investor relations, and media company, today announced that "The RedChip Money Report: Small Stocks Big Money" television program will feature two emerging growth companies on Fox Business nationwide on Thursday, February 27, 2014 at 10:00 p.m. Pacific (1 a.m. EST). The show will also air on Bloomberg U.K. Saturday, March 1, 2014 at 12:30 a.m. GMT; on Bloomberg Europe Sunday, March 2, 2014 at 8:30 a.m. and 3:30 p.m. GMT; and on Bloomberg Asia on Sunday March 2, 2014 at 3:30 p.m. HKT.

Public Outcry Over Mavuno Church "Gerrit" Poster
by Khikami Obbayi - All Africa Global Media - Wed Feb 26, 12:01AM CST
The Mavuno Church over the weekend put up a controversial poster which has been trending on Social Media as people weigh in on the debate of the appropriateness of the poster's design. The poster which is an advert for a series of sermons to be held during services for the month of March incorporates a picture of would be teens in a presumably intimate position together with titles to secular songs including a controversial book title.

ChromaDex CEO to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference on Wednesday, January 22nd at 8:30 am EST
PR Newswire - Fri Jan 17, 7:30AM CST
ChromaDex Corp.® (OTCBB: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today that its CEO, Frank Jaksch, will present at "TEN," Noble Financial Capital Markets' Tenth Annual Equity Conference at Club Med in Sandpiper Bay, Florida in Room 2 on Wednesday, January 22, 2014 at 8:30 am EST.

ChromaDex CEO Frank Jaksch to Be Interviewed Today on Clear Channel Business Talk Radio DFW 1190AM
Marketwire - Mon Jan 06, 9:12AM CST
ChromaDex(R) Corporation (OTCBB: CDXC) ("ChromaDex" or the "Company", an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today its CEO Frank Jaksch will be interviewed live today by Michal Yorba on Clear Channel Business Talk Radio's The Traders Network. The interview will air on Monday, January 6, 2014, at 2:45pm CST / 12:45pm PST / 3:45pm EST.

ChromaDex® Announces $62 Million Ingredient Agreement with Network Marketing Company 5LINX®
PR Newswire - Mon Jan 06, 7:30AM CST
ChromaDex Corporation® (OTCBB: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today it has entered into a four year ingredient supply and brand licensing agreement valued at approximately $62 million, with 5LINX®, one of the largest and fastest-growing direct marketing companies in the world.

ChromaDex® Appoints Former Nestle Executive to Its Board of Directors
PR Newswire - Fri Jan 03, 7:30AM CST
ChromaDex® Corporation (OTCQB: CDXC) ("ChromaDex" or the "Company", an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today an addition to its board of directors with the appointment of Steve Allen as an independent director.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Domino's Probe Puts Franchise Disclosure Under Lens

Updated Category News Views 110

A franchisee's shuttered stores can turn cheerful unit-growth talk into a nasty accounting of credibility, and that is the uncomfortable territory Domino's now occupies. Kahn Swick & Foti has opened an investigation into whether Domino's officers and directors breached fiduciary duties or violated state or federal law. That is not a finding of misconduct. It is a legal...

Continue Reading
COFE+ Barista Test Puts Robotic Coffee on the Clock

Updated Category News Views 84

A swan latte taking 18 seconds less is not nothing, even if it is hardly a verdict on the future of coffee. COFE+, the seventh-generation robotic barista from Shanghai Hi-Dolphin Robot Technology, beat an award-winning human barista across five drinks at a live November 14 competition in Yiwu. That is a clean, visible demonstration of what machines are increasingly built...

Continue Reading
Workers Are Burning Savings as Pay Falls Behind Costs

Updated Category News Views 69

Payroll optimism has been ground into dust by the ordinary bills nobody can dodge. Monster's 2026 Cost of Living Report says 93% of employed U.S. workers feel their wages are failing to keep up with costs, barely different from 95% in both 2024 and 2025. That is not a blip, and it is not workers merely grousing about prices. Three years of nearly identical frustration...

Continue Reading
Industrial Air Compressors: Fix, Rebuild, or Replace

Updated Category News Views 90

A compressor’s ugliest invoice is rarely the one from the service technician. It is the one nobody sees at first: a stalled production line, missed output, overtime, wasted electricity, and a maintenance crew chasing the same machine again next month. Pam Mahood of Waterloo, Iowa-based Compressed Air & Equipment Co. puts the decision where it belongs—not on the price...

Continue Reading
Faex Health Adds Ebola and H. pylori AI Screening Tools

Updated Category News Views 82

A smartphone pointed at a toilet is an awkward place to hunt for medical progress, yet Faex Health is making a serious attempt to turn that daily evidence into an early-warning tool. The company has added investigational pre-screening capabilities for Ebola virus disease and Helicobacter pylori, or H. pylori, bringing its internally validated panel to 18 gastrointestinal...

Continue Reading
California Stone Ban Puts a Hidden Worker Toll in View

Updated Category News Views 42

Countertops are supposed to finish a kitchen, not quietly wreck the lungs of the people cutting them. Yet California's move toward prohibiting the fabrication and installation of artificial stone containing more than 1% crystalline silica puts an ugly, long-running occupational-health problem in plain sight. This is not a story that calls for chest-thumping market talk....

Continue Reading
AI Governance Is Becoming Enterprise Infrastructure

Updated Category News Views 69

Governance Has Finally Reached the Engine Room Enterprise AI is no longer a shiny pilot parked in some innovation lab; it is creeping into business-critical work, and that changes the argument entirely. Frost & Sullivan’s latest analysis makes a sensible point that too many executives still resist: AI governance is becoming a strategic operating capability, not merely a...

Continue Reading
Sivers Moves Q3 Release to Accommodate U.S. Investors

Updated Category News Views 74

Thanksgiving has a nasty habit of turning perfectly ordinary earnings dates into ghost towns, and Sivers Semiconductors has sensibly stepped around that pothole. The company will publish its third-quarter 2026 interim report on Monday, November 30, rather than Thursday, November 26. That is not a strategy reset, a warning, or some grand corporate mystery. It is a calendar...

Continue Reading
Chicago Kertész Show Puts Photography's Quiet Giant First

Updated Category News Views 112

A fork, a plate, and a sharp eye can outlast plenty of louder art. Leica Gallery Chicago is putting that proposition on the wall with André Kertész: The Master, opening December 4, 2026 and running through January 17, 2027. More than thirty signature works is not a sprawling museum survey, and frankly that may be the point. Kertész did not need grand scale to make his...

Continue Reading
Rosalind Franklin University’s $23.8M Scholarship Win

Updated Category News Views 80

Twenty-three million dollars can disappear fast in graduate health education, which is exactly why Rosalind Franklin University’s campaign result deserves more than a polite round of applause. The university’s five-year Empowering Scholars effort closed in June 2026 with $23,836,272 raised, clearing its $20 million target by roughly 19%. In a world where institutions...

Continue Reading

Top 5 Most Recently Viewed Articles

Ecomondo 2025: A Hub for Global Eco-Innovation and Research

Updated Category News Views 288

Introduction to Ecomondo 2025 Set to take place from November 4 to 7, Ecomondo 2025 will feature an impressive lineup of 1,700 exhibiting brands and 350 buyers representing 66 countries at the Rimini Expo Centre. This event showcases Europe's commitment to ecological transition and is renowned as a vital platform for discussions surrounding the green, blue, and circular...

Continue Reading
Apple App Store Revenue Soars by 15% in Fiscal 2025 Q1

Updated Category News Views 598

Impressive Revenue Growth for Apple's App Store Apple's App Store has made headlines once again with its remarkable revenue growth. In the first quarter of fiscal 2025, the revenue climbed by a whopping 15% year-over-year, hitting an impressive $8.1 billion. This surge has caught the attention of analysts and investors alike. Surge in Downloads and Yearly Growth During...

Continue Reading
Insider Trends: Big Bets on Broadcom Options Trading

Updated Category News Views 263

Smart Money Observations in Broadcom Options Recently, significant players in the market have shown a pronounced interest in Broadcom. It appears that some investors are taking a bearish stance, suggesting a cautious outlook on the stock's future performance. Understanding Broadcom's Options History Reviewing the historical options data for Broadcom (NASDAQ: AVGO), it...

Continue Reading
KBRA Announces Ratings for BX 2024-SLCT Securitization Deal

Updated Category News Views 217

KBRA Assigns Preliminary Ratings to BX 2024-SLCT KBRA has officially announced the assignment of preliminary ratings to several classes of BX 2024-SLCT, indicating a significant step in the CMBS single-borrower securitization market. Details of the Securitization Transaction The transaction revolves around a substantial floating-rate mortgage loan amounting to $615...

Continue Reading
Investigation into Shareholder Rights for BCOV, ENLC, CCRN

Updated Category News Views 192

Investigation into Shareholder Rights Halper Sadeh LLC, a prominent law firm focused on investor rights, is engaging in a comprehensive investigation regarding several companies regarding potential violations of federal securities laws and fiduciary duties to shareholders. Brightcove Inc. and Its Recent Sale Brightcove Inc. (NASDAQ: BCOV) has announced a sale to Bending...

Continue Reading